XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
NOTE C - EARNINGS PER SHARE (Tables)
6 Months Ended
Oct. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Reconciliation of the weighted average shares outstanding for basic and diluted Earnings Per Share are as follows:

 
 
Six months
   
Three months
 
 
 
Periods ended October 31,
 
 
 
2017
   
2016
   
2017
   
2016
 
Weighted average shares outstanding:
                       
Basic
   
8,830,486
     
8,771,494
     
8,834,945
     
8,780,633
 
Effect of dilutive securities
   
**
 
   
**
 
   
**
 
   
**
 
Diluted
   
8,830,486
     
8,771,494
     
8,834,945
     
8,780,633
 
** For the six and three month periods ended October 31, 2017, dilutive securities are excluded since the inclusion of such shares would be antidilutive due to the net loss for the periods.  The exercisable shares excluded are 1,353,750. The effect of dilutive securities for the periods would have been 129,245 and 117,209, respectively.  For the six and three month periods ended October 31, 2016, dilutive securities are excluded since the inclusion of such shares would be antidilutive due to the net loss for the periods.  The exercisable shares excluded are 1,265,375. The effect of dilutive securities for the periods would have been 184,793 and 190,418, respectively.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
The computation of diluted earnings per share in the other fiscal periods excludes those options and stock appreciation rights (“SARS”) with an exercise price in excess of the average market price of the Company’s common shares during the periods presented. The inclusion of such options and SARS in the computation of earnings per share would have been antidilutive. The number of excluded options and SARS were:

 
 
Six months
   
Three months
 
 
 
Periods ended October 31,
 
 
 
2017
   
2016
   
2017
   
2016
 
Outstanding options and SARS excluded
   
- **
 
   
- **
 
   
- **
 
   
- **